These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7521509)

  • 41. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
    Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
    Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.
    Nio Y; Zighelboim J; Berek JS; Bonavida B
    Nat Immun Cell Growth Regul; 1990; 9(4):283-96. PubMed ID: 2215516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures.
    Fuchshuber PR; Lotzová E
    Lymphokine Cytokine Res; 1992 Oct; 11(5):271-6. PubMed ID: 1281676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative studies of human FcRIII-positive and negative natural killer cells.
    Nagler A; Lanier LL; Cwirla S; Phillips JH
    J Immunol; 1989 Nov; 143(10):3183-91. PubMed ID: 2530273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The IL-12 signature: NK cell terminal CD56+high stage and effector functions.
    Loza MJ; Perussia B
    J Immunol; 2004 Jan; 172(1):88-96. PubMed ID: 14688313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
    J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.
    Anegón I; Cuturi MC; Trinchieri G; Perussia B
    J Exp Med; 1988 Feb; 167(2):452-72. PubMed ID: 2831292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cells.
    Takayama E; Koike Y; Ohkawa T; Majima T; Fukasawa M; Shinomiya N; Yamaguchi T; Konishi M; Hiraide H; Tadakuma T; Seki S
    Immunology; 2003 Feb; 108(2):211-9. PubMed ID: 12562330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
    Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
    Ortaldo JR; Frey J; Takeshita T; Sugamura K
    Eur Cytokine Netw; 1990; 1(1):27-34. PubMed ID: 2151685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
    Brunda MJ; Tarnowski D; Davatelis V
    Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.
    Pang G; Buret A; Batey RT; Chen QY; Couch L; Cripps A; Clancy R
    Immunology; 1993 Jul; 79(3):498-505. PubMed ID: 7691728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME; Thiele DL; Lipsky PE
    J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation.
    Warren HS; Skipsey LJ
    Immunology; 1991 Jan; 72(1):150-7. PubMed ID: 1825480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resting human peripheral blood lymphocytes can be activated to cytolytic function by antibodies to CD3 in the absence of exogenous interleukin-2.
    Scott CF; Lambert JM; Bolender S; Blattler WA
    Cell Immunol; 1988 Jul; 114(2):370-84. PubMed ID: 3260543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.
    Vie H; Bonneville M; Sondermeyer P; Moreau JF; Soulillou JP
    Immunology; 1986 Mar; 57(3):351-7. PubMed ID: 3082744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.